Hula, a Physical Activity Intervention for Female-Cancer Survivors
1 other identifier
interventional
73
1 country
1
Brief Summary
A six-month interventional program to determine the biological and psychosocial effects of hula as a form of physical activity for female breast, cervical, endometrial or ovarian cancer survivors living on Oahu.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2013
CompletedFirst Submitted
Initial submission to the registry
January 20, 2015
CompletedFirst Posted
Study publicly available on registry
January 30, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedApril 18, 2019
April 1, 2019
4.3 years
January 20, 2015
April 16, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hula Program Feasibility (Compliance as measured by the proportion of total sessions attended and a questionnaire regarding satisfaction with the program at the end of the intervention)
Compliance as measured by the proportion of total sessions attended and a questionnaire regarding satisfaction with the program at the end of the intervention
6 months after the start of the intervention program
Secondary Outcomes (12)
Biomarkers - Sex Hormones (Circulating levels of sex hormones measured in serum samples)
Baseline, 6 months and 12 months after the start of the intervention program
Biomarkers - Cytokines (Circulating levels of cytokines measured in serum samples.)
Baseline, 6 months and 12 months after the start of the intervention program
Biomarkers - Inflammatory Markers (Circulating levels of leptin, CRP, IGF-1, and IGFBP3 measured in serum samples collectively.)
Baseline, 6 months and 12 months after the start of the intervention program
DNA Methylation Patterns (DNA methylation patterns as detected with the Illumina Assay containing methylation sites in RefSeq genes and CpG islands collectively.)
Baseline, 6 months and 12 months after the start of the intervention program
Self-Report Outcomes - Demographics (Collectively looking at demographic items as measured on the baseline questionnaire, including ethnicity, education, family, history of cancer, stage of cancer, treatment type, and comorbidities.)
Baseline, 6 months and 12 months after the start of the intervention program
- +7 more secondary outcomes
Study Arms (1)
Hula
OTHERHula is an ancient, Native Hawaiian dance form of cultural expression and physical activity. Participants will attend one-hour hula classes twice a week for six months.
Interventions
Eligibility Criteria
You may qualify if:
- Lives on Oahu
- Diagnosed with primary breast,cervical, endometrial or ovarian cancer (stage I-III)
- Completed initial regional and systemic treatment for breast cancer 2 months ago
- Physically capable of doing the hula-based physical activity
- Receives approval by attending physician to participate in trial
You may not qualify if:
- Currently undergoing chemotherapy or radiation therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Hawaii Cancer Center
Honolulu, Hawaii, 96813, United States
Related Publications (1)
Bantum EO, Yamada PM, Makolo T, Yu H, Pagano I, Subia N, Walsh C, Loo LWM. Hula as a physical activity and social support intervention for sustained activity in female breast and gynecologic cancer survivors. Front Psychol. 2023 Oct 24;14:1190532. doi: 10.3389/fpsyg.2023.1190532. eCollection 2023.
PMID: 37941759DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Erin Bantum, MA, PhD
University of Hawaii Cancer Research Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 20, 2015
First Posted
January 30, 2015
Study Start
September 1, 2013
Primary Completion
December 1, 2017
Study Completion
December 1, 2017
Last Updated
April 18, 2019
Record last verified: 2019-04
Data Sharing
- IPD Sharing
- Will not share